Essilor International SA (ESLOY) Receives Average Recommendation of “Strong Buy” from Analysts

Shares of Essilor International SA (NASDAQ:ESLOY) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation.

Brokers have set a one year consensus price objective of $70.50 for the company, according to Zacks. Zacks has also assigned Essilor International SA an industry rank of 175 out of 265 based on the ratings given to related companies.

A number of equities analysts have recently commented on ESLOY shares. Zacks Investment Research lowered shares of Essilor International SA from a “hold” rating to a “sell” rating in a research report on Tuesday, March 21st. Credit Suisse Group AG started coverage on shares of Essilor International SA in a research report on Friday, March 17th. They issued an “outperform” rating for the company. Finally, Barclays PLC started coverage on shares of Essilor International SA in a research report on Thursday, March 9th. They issued an “overweight” rating for the company.

Shares of Essilor International SA (NASDAQ:ESLOY) opened at 66.91 on Tuesday. The stock’s 50 day moving average is $64.29 and its 200-day moving average is $58.77. Essilor International SA has a one year low of $50.35 and a one year high of $67.99. The company has a market cap of $28.97 billion and a P/E ratio of 33.07.

WARNING: This piece of content was originally posted by Mideast Time and is the sole property of of Mideast Time. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at

About Essilor International SA

Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:ESLOY”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Get a free copy of the Zacks research report on Essilor International SA (ESLOY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2017 Mideast Time.